Literature DB >> 8781022

Role of vesicle-mediated transport pathways in hepatocellular bile secretion.

J M Crawford1.   

Abstract

Bile formation by hepatocytes involves the secretion of organic and inorganic solutes derived from a number of intracellular sources. Plasma-to-bile trafficking of bile salts and proteins, in particular, is a major route for solute movement through the hepatocyte. Intracellular vesicle trafficking is the primary pathway for delivery of plasma proteins to bile, via either fluid-phase or receptor-mediated endocytosis. In contrast, bile salts do not appear to traffic via vesicles. Rather, bile salts appear to promote the insertion of vesicles containing the apical transport proteins into the hepatocyte canalicular membrane. Lysosomal protein also is released into bile by fusion of vesicles or possibly of tubular lysosomes with the canalicular membrane. Structural phospholipid is presumably delivered to the canalicular membrane as part of vesicular traffic, but biliary phosphatidylcholine molecules are more likely delivered via binding to cytosolic transfer proteins. Cholesterol may be delivered either via cystolic proteins or via vesicular trafficking, the latter in conjunction with sphingomyelin recycling to and from the canalicular membrane. Lastly, the primary mechanism for phospholipid secretion into bile appears to be the budding of phospholipid vesicles from the exoplasmic hemileaflet of the hepatocyte canalicular membrane. Thus, vesicle-mediated pathways play a major role in a number of bile secretory mechanisms.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8781022     DOI: 10.1055/s-2007-1007230

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  16 in total

1.  Infection of polarized cultures of human intestinal epithelial cells with hepatitis A virus: vectorial release of progeny virions through apical cellular membranes.

Authors:  C A Blank; D A Anderson; M Beard; S M Lemon
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

Review 2.  Hepatocyte polarity.

Authors:  Aleksandr Treyer; Anne Müsch
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

Review 3.  Physiological and molecular biochemical mechanisms of bile formation.

Authors:  Vasiliy Ivanovich Reshetnyak
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

4.  Endogenous syntaxins 2, 3 and 4 exhibit distinct but overlapping patterns of expression at the hepatocyte plasma membrane.

Authors:  H Fujita; P L Tuma; C M Finnegan; L Locco; A L Hubbard
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

5.  Co-injection of a targeted, reversibly masked endosomolytic polymer dramatically improves the efficacy of cholesterol-conjugated small interfering RNAs in vivo.

Authors:  So C Wong; Jason J Klein; Holly L Hamilton; Qili Chu; Christina L Frey; Vladimir S Trubetskoy; Julia Hegge; Darren Wakefield; David B Rozema; David L Lewis
Journal:  Nucleic Acid Ther       Date:  2012-12       Impact factor: 5.486

Review 6.  Recent Advances in the Critical Role of the Sterol Efflux Transporters ABCG5/G8 in Health and Disease.

Authors:  Helen H Wang; Min Liu; Piero Portincasa; David Q-H Wang
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

7.  Hepatic secretion of phospholipid vesicles in the mouse critically depends on mdr2 or MDR3 P-glycoprotein expression. Visualization by electron microscopy.

Authors:  A R Crawford; A J Smith; V C Hatch; R P Oude Elferink; P Borst; J M Crawford
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

Review 8.  Bile formation and secretion.

Authors:  James L Boyer
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

Review 9.  Cholestasis.

Authors:  R Oude Elferink
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

10.  Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo.

Authors:  Coleen R Kaiser; Michelle L Flenniken; Eric Gillitzer; Ann L Harmsen; Allen G Harmsen; Mark A Jutila; Trevor Douglas; Mark J Young
Journal:  Int J Nanomedicine       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.